24th September 2013
Conference Room, Mt E Novena Hospital
Dr Wong Sin Yew, Director and Infectious Disease Physician at Infectious Disease Specialist @ Novena gave an update on new antibiotics.He discussed some of the new antibiotics thatwere registered in 2013and some which are currently in Phase 3 Clinical Trials with registration targets in 2014.
Dr Wong provided a detailed explanation regarding the need for new antibiotics. Recent reports of MDRO (Multi-Drugs Resistant Organisms) have been one of the major factorsin the quest for new antibiotics. Examples of the MDRO are VRE (Vancomycin-Resistant Enterococcus), MDR Pseudomonas (Multi-Drug Pseudomonas aeruginosa) and VRSA (Vancomycin-resistant Staphylococcus Aureus).
Dr Wong also discussed the problem of MRSA (Methicillin Resistant Staphylococcus Aureus). MRSA often starts as a skin infectionand may be classified as Community acquired or Hospital acquired. MRSA can be transmitted from person to person by direct skin contact. In the community setting, this is commonly seen in teenagers or adults who are active in contact-sports.
Dr Wong reinforced the need for rapid and appropriateantibiotic management for drug-resistant infections. He reinforced the following points:
- Prevention of Infection
- Trace and track resistant bacteria
- Improve use of antibiotics
- Promote development for new antibiotic and tests for resistance
All health care workers should be compliant to infection control practices.